Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Price Target

Price Target

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Ratings
  • Earnings
  • Guidance
  • Markets
  • News
  • Price Target
  • Trading Ideas

These Analysts Cut Their Forecasts On Air Products And Chemicals After Downbeat Earnings

By Avi Kapoor
February 6, 3:40 PM
Air Products and Chemicals, Inc. (NYSE: APD) reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS guidance below estimates on Monday.

APD

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Equities
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Trading Ideas

JP Morgan’s Bullish View On This Chinese Biotech, Says Pullback Creates Entry Point

By Vandana Singh
February 6, 3:37 PM
BeiGene's JP Morgan coverage highlights upside in valuation post-pullback. Brukinsa's success and Tevimbra's potential add to the optimism. Overweight rating, $185 price target.

BGNE

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Price Target
  • Trading Ideas

UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst

By Vandana Singh
February 6, 3:19 PM
UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.

ABBV

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation
  • Movers
  • News
  • Price Target
  • Tech
  • Trading Ideas

Broadcom’s Tech Dominance Affirmed by JPMorgan Analyst; Forecasts Company Will Lead AI and Cloud Revolution

By Anusuya Lahiri
February 6, 3:11 PM
JPMorgan analyst initiates coverage of Broadcom with Overweight rating and $1,550 price target. Broad strengths in semiconductors and software.

AVGO

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Equities
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Trading Ideas

4D Molecular Therapeutics’ 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast

By Vandana Singh
February 6, 3:05 PM
4D Molecular Therapeutics' 4D-150 Phase 2 results for wet AMD treatment. BMO Capital optimistic, target price raised to $70.

FDMT

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Earnings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Top Stories
  • Trading Ideas

Chegg AI Investments Not Translating To Improved Fundamentals, Analysts Dive Deeper Into Q4 Print

By Priya Nigam
February 6, 1:47 PM
Shares of Chegg Inc (NYSE: CHGG) slipped in early trading on Tuesday, after declining more than 8% in the premarket session.

CHGG

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas

Palantir Rallies Off AI-Driven Q4 Earnings: Bull Analyst Sees ‘Off The Charts Commercial Success’

By Priya Nigam
February 6, 12:26 PM
Shares of Palantir Technologies Inc (NYSE: PLTR) were climbing Tuesday after the company reported better-than-expected fourth-quarter results.

PLTR

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Earnings
  • General
  • Movers
  • News
  • Price Target
  • Reiteration
  • Restaurants
  • Top Stories
  • Trading Ideas

McDonald’s Downgrade ‘Driven By Lack Of Earnings Catalysts,’ 3 Analysts Discuss Q4 Print

By Priya Nigam
February 6, 11:47 AM
Shares of McDonald's Corp (NYSE: MCD) dipped on Monday after the fast-food company reported mixed results for its fourth quarter, citing weak s

MCD

Read More
2 minute read
  • Analyst Ratings
  • Earnings
  • Markets
  • News
  • Price Target
  • Trading Ideas

Chipotle Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

By Avi Kapoor
February 6, 11:20 AM
Chipotle Mexican Grill, Inc. (NYSE: CMG) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 6, 2024.

CMG

Read More
2 minute read
  • Analyst Ratings
  • Dividends
  • Long Ideas
  • Markets
  • News
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

These 3 Utilities Stocks Delivering High-Dividend Yields Are Recommended By Wall Street’s Most Accurate Analysts

By Avi Kapoor
February 6, 9:41 AM
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

DUK

Posts pagination

Previous 1 … 108 109 110 … 2,160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service